Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tenaya Therapeutics, Inc. - Common Stock (NQ:TNYA)

0.8148 -0.0262 (-3.12%)
Streaming Delayed Price Updated: 9:42 AM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tenaya Therapeutics, Inc. - Common Stock

News headline image
Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-In-Class Cardiovascular Therapeutics
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor at European Society of Cardiology Heart Failure 2022 Conference
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Present Preclinical Data on TN-401 PKP2 Gene Therapy Program at Heart Rhythm 2022
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Updates
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Participate in Upcoming Investor Conferences
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics Provides 2022 Business Updates
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics Appoints Karah Parschauer, J.D., to Its Board of Directors and Joanna Auch as Senior Vice President of People and Culture
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics Announces the Addition of Dr. June Lee to its Board of Directors
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences
From Tenaya Therapeutics
Via Business Wire
News headline image
Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics to Present at Morgan Stanley 19th Annual Global Healthcare Conference
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
From Tenaya Therapeutics, Inc.
Via Business Wire
News headline image
Tenaya Therapeutics Announces Pricing of Upsized Initial Public Offering
From Tenaya Therapeutics, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.